在多发性骨髓瘤进展和治疗期间,免疫微环境分析的进展
Junzhe Bai1, Nao Nishimura1, Yawara Kawano2
1Department of Hematology, Rheumatology, and Infectious Diseases, Faculty of Life Sciences, Graduate School of Medical Sciences, Kumamoto University, 1-1-1 Honjo, Chuo-Ku, Kumamoto, 860-8556, Japan.
International journal of hematology
|November 17, 2025
概括
最近针对多发性骨髓瘤 (MM) 的疗法重塑了骨髓免疫微环境. 了解这些免疫变化是改善MM治疗和开发新疗法的关键.
科学领域:
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
- 在瘤学瘤学.
背景情况:
- 多发性骨髓瘤 (MM) 的治疗方法有了显著的进步.
- 这些疗法影响骨髓免疫微环境,对MM至关重要.
- 免疫失调发生在早期,即使在前体状况中,如意义不明的单克隆性胃病变和燃烧的MM.
研究的目的:
- 在MM进展期间审查免疫细胞动态.
- 讨论当前疗法如何调节免疫微环境.
- 突出免疫相互作用在MM病原和治疗反应中的作用.
主要方法:
- 文献综述综合了对MM免疫细胞动态的最新见解.
- 分析免疫调节药物,蛋白酶体抑制剂和基于细胞的疗法如何影响免疫微环境.
- 检查在前体和活跃MM阶段的免疫变化.
主要成果:
- MM细胞操纵免疫微环境,以逃避抗瘤免疫.
- 疗法可以激活抗瘤免疫力,但也可以维持免疫抑制途径.
- 免疫变化是渐进的,从早期的前体阶段开始.
结论:
- 深入了解MM免疫格局对于治疗优化至关重要.
- 准免疫相互作用可以克服治疗阻力.
- 获得的见解将指导多发性骨髓瘤新型免疫疗法的开发.
更多相关视频
相关概念视频
02:17The Tumor Microenvironment
7.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
7.6K
01:27Tumor Immunotherapy
1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K